Sintaho Pharmaceutical
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A clinical-stage biotech developing novel oncology and immunology therapies through targeted drug discovery.
OncologyImmunology
Technology Platform
A proprietary platform for the discovery and development of targeted small molecules and biologics focused on the tumor microenvironment and immune modulation.
Opportunities
Significant market growth in China for targeted cancer therapies and potential for out-licensing deals with global partners.
Risk Factors
High clinical development risk and potential for rapid obsolescence if newer, more effective mechanisms emerge.
Competitive Landscape
Faces intense competition from both global pharma giants and a crowded field of domestic Chinese biotechs in the immuno-oncology space.